Following an in-depth portfolio review, we've reached an agreement to sell approximately 51% of our Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287 ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Robert VanHimbergen; Chief Financial Officer, Senior Vice President; Hillenbrand Inc ...

LyondellBasell Industries N.V. (NYSE:LYB), a global leader in the chemical industry with a market capitalization of $25.49 billion, finds itself at a crossroads as it navigates through a complex ...

Arizona's electric utilities are planning for more nuclear power as part of a new look for this energy source and the ...

Aside from redefining how bonds are traded, ETFs are creating new investment opportunities for institutional and retail ...

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Detailed price information for Lyondellbasell Industries NV (LYB-N) from The Globe and Mail including charting and trades.

The goal of QR-02 is to treat and reduce dysplasia levels, potentially offering a curative solution for oral leukoplakia, an outcome that would mark a significant breakthrough in oral medicine. By ...

Moreover, according to the International Energy Agency (IEA), their market value could quadruple by 2040, reaching $420 billion under the Announced Pledges Scenario (APS ... capital. Even for some ...

“Oricidin’s innovative dental gel represents a significant advancement in the treatment of periodontitis,” said Allan Wehnert, Founder and CEO of Orocidin. “By combining cutting-edge science with ...